Linox Smart S DX PME/Master Study

NCT01090401 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2011-11-16

No results posted yet for this study

Summary

The objective of this study is to prove the safety and efficacy of the Linox smart S DX ICD lead.

Conditions

  • ICD Indication

Interventions

DEVICE

Linox smart S DX

ICD lead

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-12-31
Completion
2011-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01090401 on ClinicalTrials.gov